CONNECT WITH US
eCommerce

eCommerce

APR Expands Medicube Distribution Across Canada

Global Cosmetics News logo

Published on

Add as a preferred source on Google
APR Expands Medicube Distribution Across Canada

THE WHAT? South Korean cosmetics company APR has expanded its Medicube skincare brand into approximately 1,300 Shoppers Drug Mart stores across Canada, strengthening its North American retail distribution network as demand for K-Beauty continues to grow.

THE DETAILS The nationwide rollout introduces 13 Medicube skincare products across Shoppers Drug Mart, Canada’s largest drugstore chain and a subsidiary of Loblaw. The range includes Zero Pore Pad, PDRN Pink Peptide Ampoule, PDRN Pink Collagen Gel Mask and Deep Vita C Capsule Cream. APR plans to expand the assortment according to local demand and sales performance. The company is also preparing to launch Medicube through Costco Canada, further extending its physical retail presence. Meanwhile, six Medicube products ranked among Amazon Canada’s top 100 facial skincare bestsellers in early November. According to NielsenIQ, Canadian sales of Korean cosmetics increased 57 percent last year to US$164 million.

THE WHY? The expansion highlights the growing importance of major retail partnerships in accelerating the international growth of South Korean cosmetics brands. By securing nationwide distribution through Shoppers Drug Mart and expanding into Costco, APR is strengthening Medicube’s market penetration, reducing its reliance on ecommerce and increasing competition within Canada’s mass and premium skincare sectors. The strategy also demonstrates how established Korean cosmetics companies are using multichannel distribution to build scale across North America.



Source link
Related Topics:eCommerce

Disclaimer

We strive to uphold the highest ethical standards in all of our reporting and coverage. We TheMorningPulse.fyi want to be transparent with our readers about any potential conflicts of interest that may arise in our work. It's possible that some of the investors we feature may have connections to other businesses, including competitors or companies we write about. However, we want to assure our readers that this will not have any impact on the integrity or impartiality of our reporting. We are committed to delivering accurate, unbiased news and information to our audience, and we will continue to uphold our ethics and principles in all of our work. Thank you for your trust and support.